Literature DB >> 22358621

Production of human-mouse chimeric antibody by high cell density perfusion culture.

Y Takazawa1, M Tokashiki.   

Abstract

Two mouse myeloma cell lines which were transfected with chimeric mouse variable-human constant immunoglobulin heavy and light chain genes have been cultured at high cell density in a settling perfusion culture vessel to produce chimeric antibody specific for human common acute lymphocytic leukemia antigen (cALLA).J558L transfectant proliferated well in a serum-free medium (ITES-eRDF) to a viable cell density of 3.7×10(7) cells/ml and produced chimeric antibody to a maximum value of 60 μg/ml in 120 ml scale vessel. X63Ag8.653 transfectant reached a density of 1.9×10(7) cells/ml in 1.2 I scale vessel in serum supplemented medium (10% FCS-eRDF) and produced chimeric antibody which consisted of chimeric gamma and chimeric kappa chains to a maximum value of 5.8 μg/ml.

Entities:  

Year:  1989        PMID: 22358621     DOI: 10.1007/BF00386141

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  21 in total

1.  Suppression of tumor growth by in vivo administration of a recombinant human-mouse chimeric monoclonal antibody.

Authors:  M Yokoyama; Y Nishimura; T Watanabe
Journal:  Jpn J Cancer Res       Date:  1987-11

2.  Escherichia coli secretion of an active chimeric antibody fragment.

Authors:  M Better; C P Chang; R R Robinson; A H Horwitz
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

3.  Expression of mouse::human immunoglobulin heavy-chain cDNA in lymphoid cells.

Authors:  A Y Liu; P W Mack; C I Champion; R R Robinson
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Secretion and processing of an immunoglobulin light chain in Escherichia coli.

Authors:  O Zemel-Dreasen; A Zamir
Journal:  Gene       Date:  1984-03       Impact factor: 3.688

6.  Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.

Authors:  L K Sun; P Curtis; E Rakowicz-Szulczynska; J Ghrayeb; N Chang; S L Morrison; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Antiviral activities of human monoclonal antibodies to herpes simplex virus.

Authors:  S Fujinaga; T Sugano; Y Matsumoto; Y Masuho; R Mori
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

8.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose.

Authors:  R C Duhamel; P H Schur; K Brendel; E Meezan
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

10.  Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.

Authors:  Y Nishimura; M Yokoyama; K Araki; R Ueda; A Kudo; T Watanabe
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

View more
  3 in total

Review 1.  Serum-free medium for fermentor cultures of hybridomas.

Authors:  O W Merten; J Litwin
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

Review 2.  Perfusion culture apparatus for suspended mammalian cells.

Authors:  M Tokashiki; H Takamatsu
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Comparison of culture methods for human-human hybridomas secreting anti-HBsAg human monoclonal antibodies.

Authors:  Y Shintani; Y Kohno; H Sawada; K Kitano
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.